CRISPR Therapeutics
CRSP
#3565
Rank
C$5.65 B
Marketcap
C$58.34
Share price
1.43%
Change (1 day)
-24.94%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): C-$6.63

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is C-$6.79. In 2025 the company made an earnings per share (EPS) of C-$9.34 a decrease over its 2024 EPS that were of C-$6.26.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$6.63-29.04%
2025C-$9.3449.2%
2024C-$6.26
2022C-$11.99-267.74%
2021C$7.15
2019C$1.59-132.36%
2018C-$4.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.93-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA